Oncology

Taking on the challenge of opening up new opportunities for retinoblastoma care

We need to reevaluate our approach to kidney disease and its classification

Kidney tumor with dual cell population, features of emperipolesis, cyclin D1 positivity.

A new grading system for prostate carcinoma – and how you can adopt it in your laboratory

Ian Cree, Head, WHO Classification of Tumors Group, International Agency for Research on Cancer

As a qualitative assay, immunohistochemistry does the job. But do we need more?

Are single-cell diagnostics needed to reveal the full picture in breast cancer?

Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients

Can the microbiome predict the likelihood of chemotherapy side effects?

Guidelines recommend the Pap smear and HPV testing for cervical cancer – but are both necessary?